We wish to bring to the attention of patients and members of the public that revised and updated clinical policies on the following treatments have been approved by the CCG. These are:
- Policy for the Supply and Funding of Insulin Pumps for Patients with Diabetes Mellitus
- Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring for patients with Diabetes Mellitus
- Policy for the management of Otitis Media with Effusion (OME) using grommets
- Policy for the commissioning of photorefractive surgery for the correction of refractive error
- Policy for the commissioning of Excision of the Uterus for the treatment of menorrhagia (heavy menstrual bleeding)
These polices are available on the CCG’s website.
These clinical policies explain the criteria that must be met in order for these treatments and procedures to be given on the NHS in this area.
Arrangements are being made with GPs and hospital doctors and consultants for the implementation of these policies. Whilst this takes place there will be a period during which patients who were referred for treatment under the previous versions of these policies continue to be managed under that version of the policy.
For this CCG policies A and B above are new policies.
Patients with diabetes who are already self-funding one of the devices covered in the diabetes policies, such as an insulin pump or the Freestyle Libre flash glucose monitor, may be eligible for receiving these devices on the NHS. To qualify you need to demonstrate you met the criteria outlined in the policy when you first began to use the device. You must also meet the continuation criteria.
If you have any questions about whether you are eligible for one of these treatments, you should discuss this with your clinician.